Prophylactic doxycycline (doxy) lessens rash from dacomitinib (D) an EGFR inhibitor with no rash or diarrhea improvement from corticosteroids or probiotics Meeting Abstract


Authors: Lacouture, M. E.; Keefe, D. M. K.; Sonis, S. T.; Giri, N.; Wang, T.; Reisman, A.; Sbar, E.; Gernhardt, D. R.; Jatoi, A.
Abstract Title: Prophylactic doxycycline (doxy) lessens rash from dacomitinib (D) an EGFR inhibitor with no rash or diarrhea improvement from corticosteroids or probiotics
Meeting Title: 2015 Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036903903
PROVIDER: wos
Notes: Meeting Abstract: e19049 -- Source: Wos